-
ADARx Pharmaceuticals Announces First Patient Dosed in Phase 3 STOP-HAE Clinical Trial and Orphan Drug Designation for ADX-324, a Long-Acting siRNA in Development for the Prophylactic Treatment of Hereditary Angioedema (HAE)
22 Oct 2025 13:00 GMT
… ADX-324 in patients with hereditary angioedema (HAE). Additionally, ADARx announced that …
-
Study Identifies Key Barriers and Promoters in Translating Hereditary Angioedema Research to Clinical Care
14 Oct 2025 16:41 GMT
… clinical care for patients with hereditary angioedema (HAE). The study was … Guidelines for the Management of Hereditary Angioedema. J Allergy Clin Immunol … with subcutaneous C1INH prophylaxis for hereditary angioedema: a retrospective analysis. Allergy …
-
Innovations in Hereditary Angioedema Treatment: Present & Future
11 Oct 2025 13:45 GMT
… the Management of Hereditary Angioedema: Exploring Current and Future Therapies
Hereditary Angioedema (HAE) is … the debilitating impacts of hereditary angioedema.
Subject of Research: Hereditary Angioedema Treatments and Therapies …
-
Astria Therapeutics Initiates the Phase 3 ORBIT-EXPANSE Long-Term Trial of Navenibart in People with Hereditary Angioedema
08 Oct 2025 18:39 GMT
… navenibart in people living with hereditary angioedema (HAE). "The initiation of … development for the treatment of hereditary angioedema. Our second program, STAR-0310 …
-
Misdiagnosed Hereditary Angioedema with Recurrent Abdominal Pain: A Novel SERPING1 Frameshift Variant
07 Oct 2025 18:04 GMT
… recommendations for the management of hereditary angioedema due to C1 inhibitor … , Staubach P, Hardt J. Hereditary angioedema: new findings concerning symptoms, affected … 09.064
12. Manning ME. Hereditary angioedema: differential diagnosis, diagnostic tests, …
-
NICE recommends treatment for hereditary angioedema attacks
25 Sep 2025 10:04 GMT
… use in the prevention of hereditary angioedema (HAE) attacks in people 12 …
-
KalVista Pharmaceuticals Announces European Commission and Swissmedic Approval of EKTERLY® (sebetralstat), First and Only Oral On-Demand Treatment for Hereditary Angioedema
22 Sep 2025 11:30 GMT
… treatment of acute attacks of hereditary angioedema (HAE) in adults and adolescents … ;391(1):32–43.
About Hereditary Angioedema
Hereditary angioedema (HAE) is a rare genetic … oral on-demand treatment for hereditary angioedema (HAE)—and continues to work …
-
New clinical trial offers hope for hereditary angioedema patients in Little Rock
20 Sep 2025 09:57 GMT
… offering hope to families battling hereditary angioedema (HAE), a rare and life … Dr. Sitz. He explained that hereditary angioedema is a genetic abnormality that …
-
KalVista Pharmaceuticals’ Hereditary Angioedema Drug Approved In EU, Switzerland: Retail Sees Stock Rallying To $22 In A Year
19 Sep 2025 21:52 GMT
… treatment of acute attacks of hereditary angioedema (HAE).
Ekterly was approved by … 10 years of market exclusivity.
Hereditary angioedema (HAE) is a rare genetic …
-
Intellia Therapeutics Completes Enrollment in the Global Phase 3 HAELO Study of Lonvoguran Ziclumeran (lonvo-z) for Hereditary Angioedema
18 Sep 2025 11:30 GMT
… z) for the treatment of hereditary angioedema (HAE). Topline data are … by the European Commission. About Hereditary Angioedema
Hereditary angioedema (HAE) is a rare, genetic … 2002) for the treatment of hereditary angioedema (“HAE”) pursuant to its clinical …
About
© 1995-2025